<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trialsSusan D. Richman, Philip Quirke, Katie Southward et al.|The Journal of Pathology|2015Cited by 238
Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic reviewElizabeth L. Turner, Hui‐Jie Lee, Hannah Bensoussane et al.|The Lancet Global Health|2021Cited by 32
Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)Dhiraj Tripathi, Peter Brocklehurst, Peter Hayes et al.|BMJ Open Gastroenterology|2019Cited by 18
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (<scp>CALIBRE</scp> Trial)Dhiraj Tripathi, Kelly Handley, Lisa Holden et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 11
GS-006 A multicentre randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)Dhiraj Tripathi, Ian Rowe, Kelly Handley et al.|Journal of Hepatology|2025Cited by 1